X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (406) 406
gastroenterology & hepatology (318) 318
gastroenterology and hepatology (246) 246
female (206) 206
male (199) 199
helicobacter pylori (171) 171
middle aged (161) 161
adult (153) 153
inflammatory bowel disease (127) 127
ulcerative colitis (127) 127
crohn's disease (118) 118
helicobacter infections - drug therapy (109) 109
crohns-disease (76) 76
aged (75) 75
anti-bacterial agents - therapeutic use (71) 71
treatment outcome (70) 70
prospective studies (69) 69
drug therapy, combination (66) 66
therapy (64) 64
inflammatory-bowel-disease (63) 63
diagnosis (60) 60
infliximab (59) 59
infection (54) 54
clarithromycin (53) 53
retrospective studies (53) 53
prevalence (50) 50
ulcerative-colitis (49) 49
azathioprine (48) 48
care and treatment (48) 48
efficacy (47) 47
eradication (47) 47
helicobacter pylori - drug effects (47) 47
inflammatory bowel diseases - drug therapy (45) 45
pharmacology & pharmacy (45) 45
risk factors (45) 45
colitis, ulcerative - drug therapy (44) 44
crohn disease - drug therapy (43) 43
follow-up studies (43) 43
management (43) 43
helicobacter infections - diagnosis (42) 42
microbiology (42) 42
adalimumab (40) 40
adolescent (40) 40
medicine, general & internal (40) 40
treatment (40) 40
young adult (39) 39
aged, 80 and over (38) 38
health aspects (38) 38
spain (38) 38
analysis (37) 37
gastroenterology (37) 37
surgery (37) 37
tumor necrosis factor-alpha - antagonists & inhibitors (37) 37
levofloxacin (36) 36
metaanalysis (36) 36
helicobacter pylori - isolation & purification (34) 34
helicobacter infections (33) 33
immunosuppressive agents - therapeutic use (33) 33
metronidazole (33) 33
recurrence (32) 32
time factors (32) 32
amoxicillin (30) 30
bismuth (30) 30
helicobacter infections - microbiology (30) 30
maintenance therapy (30) 30
peptic ulcer (30) 30
resistance (30) 30
gastrointestinal diseases (29) 29
helicobacter infections - complications (29) 29
double-blind (28) 28
endoscopy (28) 28
risk (28) 28
amoxicillin - therapeutic use (27) 27
antibiotic-resistance (27) 27
prognosis (27) 27
proton pump inhibitors - therapeutic use (27) 27
triple therapy (27) 27
antibodies, monoclonal - therapeutic use (26) 26
clarithromycin - therapeutic use (26) 26
proton pump inhibitor (26) 26
treatment failure (26) 26
anti-bacterial agents - administration & dosage (25) 25
anti-tnf (25) 25
oncology (25) 25
proton pump inhibitors (25) 25
sequential therapy (25) 25
severity of illness index (25) 25
abridged index medicus (24) 24
anti-inflammatory agents, non-steroidal - therapeutic use (23) 23
evidence-based consensus (23) 23
medical research (23) 23
omeprazole (23) 23
proton-pump inhibitor (23) 23
antibiotics (22) 22
breath tests (22) 22
drug administration schedule (22) 22
inflammatory bowel diseases (22) 22
remission induction (22) 22
spain - epidemiology (22) 22
6-mercaptopurine (21) 21
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Alimentary pharmacology & therapeutics, ISSN 0269-2813, 2019, Volume 50, Issue 3, pp. 258 - 268
Journal Article
The American journal of gastroenterology, ISSN 0002-9270, 03/2009, Volume 104, Issue 3, pp. 760 - 767
Journal Article
Gut, ISSN 0017-5749, 05/2012, Volume 61, Issue 5, pp. 646 - 664
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2012, Volume 380, Issue 9857, pp. 1909 - 1915
Journal Article
Clinical and experimental gastroenterology, ISSN 1178-7023, 2012, Volume 5, Issue 1, pp. 23 - 34
Traditional standard triple therapy for Helicobacter pylori (H. pylori) infection (proton pump inhibitor-clarithromycin-amoxicillin) can easily be converted to... 
Clarithromycin | Metronidazole | Helicobacter pylori | Sequential therapy | Concomitant therapy | Non-bismuth quadruple | Infection | Care and treatment | Online health care information services | Amoxicillin | Confidence intervals
Journal Article
Gut, ISSN 0017-5749, 01/2017, Volume 66, Issue 1, pp. 6 - 30
Important progress has been made in the management of Helicobacter pylori infection and in this fifth edition of the Maastricht Consensus Report, key aspects... 
CONTAINING QUADRUPLE THERAPY | C-13-UREA BREATH TEST | LOW-DOSE ASPIRIN | GASTROESOPHAGEAL-REFLUX DISEASE | PROTON-PUMP INHIBITOR | SACCHAROMYCES-BOULARDII SUPPLEMENTATION | GASTRIC-CANCER RISK | CONTAINING TRIPLE THERAPY | GASTROENTEROLOGY & HEPATOLOGY | 3RD-LINE RESCUE THERAPY | PEPTIC-ULCER DISEASE | Humans | Helicobacter Infections - prevention & control | Drug Resistance, Bacterial | Helicobacter Infections - complications | Bismuth - therapeutic use | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Nitroimidazoles - therapeutic use | Helicobacter pylori | Helicobacter Infections - drug therapy | Gastritis - microbiology | Helicobacter Infections - diagnosis | Drug Therapy, Combination | Stomach Neoplasms - diagnosis | Early Detection of Cancer | Risk Factors | Gastrointestinal Microbiome | Fluoroquinolones - therapeutic use | Clarithromycin - therapeutic use | Dyspepsia - microbiology | Gastroscopy | Evidence-Based Medicine | Proton Pump Inhibitors - therapeutic use | Stomach Neoplasms - microbiology | Amoxicillin - therapeutic use | Stomach - microbiology | Practice Guidelines as Topic | Helicobacter infections | Care and treatment | Wellness programs | Usage | Working groups | Systematic review | Staphylococcus infections | Management | Stomach cancer | Delphi method | Meta-analysis | Probiotics | Microbiota | Infectious diseases | Antibiotics | Ulcers | Patient satisfaction | Public health
Journal Article
Journal Article